Elevance Health (ELV) Equity Average (2009 - 2026)

Elevance Health (ELV) has 18 years of Equity Average data on file, last reported at $43.9 billion in Q1 2026.

• Equity Average for Q1 2026 came in at $43.9 billion, up 4.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.9 billion (up 4.45% YoY), and the FY2025 annual result was $42.7 billion, up 5.54% from the prior year.
• Equity Average held at $43.9 billion in Q1 2026 per ELV's latest filing, from $44.0 billion in the prior quarter.
• Over five years, Equity Average peaked at $44.0 billion in Q4 2025 and troughed at $36.0 billion in Q3 2022.
• A 5-year average of $40.0 billion and a median of $40.1 billion in 2024 frame the typical range for Equity Average.
• The sharpest annual moves came in 2022 and 2024: Equity Average gained 0.61% in 2022, then gained 12.13% in 2024.
• A 5-year view of Equity Average shows it stood at $36.2 billion in 2022, then rose by 7.68% to $39.0 billion in 2023, then climbed by 9.44% to $42.7 billion in 2024, then gained by 3.12% to $44.0 billion in 2025, then declined by 0.2% to $43.9 billion in 2026.
• Business Quant data shows ELV's Equity Average at $43.9 billion in Q1 2026, $44.0 billion in Q4 2025, and $44.0 billion in Q3 2025.